Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gleave

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacyC Kollmannsberger, C Moore, K N Chi, et al.
The Prostate|August 27, 1998
Differential transactivation by the androgen receptor in prostate cancer cellsR Snoek, N Bruchovsky, S Kasper, et al.
BJU International|May 15, 2004
Protein kinase C-alpha in prostate cancerM Lahn, K Sundell, M Gleave, et al.
BJU International|November 9, 2000
Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology GroupM M Elhilali, M Gleave, Y Fradet, et al.
Cell Death & Disease|October 21, 2011
OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancerV Baylot, C Andrieu, M Katsogiannou, et al.
The Prostate|August 24, 2006
The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy studyM Gleave, J Qian, C Andreou, et al.
Cancer Gene Therapy|July 30, 2005
Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoterD Yu, C Scott, W W Jia, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancerK Miller, J W Moul, M Gleave, et al.
Physical Chemistry Chemical Physics : PCCP|June 10, 2017
Correction: Dynamic nuclear polarization in a magnetic resonance force microscope experimentCorinne E Isaac, Christine M Gleave, Paméla T Nasr, et al.
Physical Chemistry Chemical Physics : PCCP|March 11, 2016
Dynamic nuclear polarization in a magnetic resonance force microscope experimentCorinne E Isaac, Christine M Gleave, Paméla T Nasr, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacyC Kollmannsberger, C Moore, K N Chi, et al.
The Prostate|August 27, 1998
Differential transactivation by the androgen receptor in prostate cancer cellsR Snoek, N Bruchovsky, S Kasper, et al.
BJU International|May 15, 2004
Protein kinase C-alpha in prostate cancerM Lahn, K Sundell, M Gleave, et al.
BJU International|November 9, 2000
Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology GroupM M Elhilali, M Gleave, Y Fradet, et al.
Cell Death & Disease|October 21, 2011
OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancerV Baylot, C Andrieu, M Katsogiannou, et al.
The Prostate|August 24, 2006
The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy studyM Gleave, J Qian, C Andreou, et al.
Cancer Gene Therapy|July 30, 2005
Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoterD Yu, C Scott, W W Jia, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancerK Miller, J W Moul, M Gleave, et al.
Physical Chemistry Chemical Physics : PCCP|June 10, 2017
Correction: Dynamic nuclear polarization in a magnetic resonance force microscope experimentCorinne E Isaac, Christine M Gleave, Paméla T Nasr, et al.
Physical Chemistry Chemical Physics : PCCP|March 11, 2016
Dynamic nuclear polarization in a magnetic resonance force microscope experimentCorinne E Isaac, Christine M Gleave, Paméla T Nasr, et al.
Pageof 4